Vitamin D deficiency in postmenopausal, healthy women predicts increased cardiovascular events: A 16-year follow-up study

European Journal of Endocrinology

Volumn 167, Issue 4, 2012, Pages 553-560

  Schierbeck, Louise Lind ^a   Rejnmark, Lars ^b,g   Tofteng, Charlotte Landbo ^a   Stilgren, Lis ^c   Eiken, Pia ^d   Mosekilde, Leif ^a,g   Køber, Lars ^e,f   Jensen, Jens Erik Beck ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c SVENDBORG HOSPITAL   (Denmark)

^d HILLERØD HOSPITAL   (Denmark)

^e Rigshospitalet   (Denmark)

^f UNIVERSITY OF COPENHAGEN   (Denmark)

^g AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DEATH; DENMARK; EDUCATIONAL STATUS; FAMILY HISTORY; FEMALE; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HUMAN; NORMAL HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SMOKING; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; WAIST HIP RATIO;

EID: 84866679077     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-12-0283     Document Type: Article

References (55)

1. Vacek JL, Vanga SR, Good M, Lai SM, Lakkireddy D & Howard PA. Vitamin D deficiency and supplementation and relation to cardiovascular health. American Journal of Cardiology 2012 109 359-363. (doi:10.1016/j.amjcard.2011.09. 020)
2. Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, Kinkeldei J, Boehm BO, Weihrauch G & Maerz W. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Archives of Internal Medicine 2008 168 1340-1349. (doi:10.1001/archinte.168.12.1340)
3. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. American Journal of Clinical Nutrition 2004 80 1678S-1688S.
4. Holick MF. The vitamin D epidemic and its health consequences. Journal of Nutrition 2005 135 2739S-2748S.
5. Lee JH, O'Keefe JH, Bell D, Hensrud DD & Holick MF. Vitamin D deficiency: an important, common, and easily treatable cardiovascular risk factor? Journal of the American College of Cardiology 2008 52 1949-1956. (doi:10.1016/j.jacc.2008.08.050)
6. Pilz S, Marz W, Wellnitz B, Seelhorst U, Fahrleitner-Pammer A, Dimai HP, Boehm BO & Dobnig H. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. Journal of Clinical Endocrinology and Metabolism 2008 93 3927-3935. (doi:10.1210/jc.2008-0784)
7. Schierbeck LL, Jensen TS, Bang U, Jensen G, Kober L & Jensen JE. Parathyroid hormone and vitamin D - markers for cardiovascular and all cause mortality in heart failure. European Journal of Heart Failure 2011 13 626-632. (doi:10.1093/eurjhf/hfr016)
8. Zittermann A & Koerfer R. Vitamin D in the prevention and treatment of coronary heart disease. Current Opinion in Clinical Nutrition and Metabolic Care 2008 11 752-757. (doi:10.1097/MCO.0b013e328312c33f)
9. Shapses SA & Manson JE. Vitamin D and prevention of cardiovascular disease and diabetes: why the evidence falls short. Journal of the American Medical Association 2011 305 2565-2566. (doi:10.1001/jama.2011.881)
10. Mullie P & Autier P. Relation of vitamin D deficiency to cardiovascular disease. American Journal of Cardiology 2011 107 956-957. (doi:10.1016/j.amjcard.2010.10.079)
11. Chacko SA, Song Y, Manson JE, Van Horn L, Eaton C, Martin LW, McTiernan A, Curb JD, Wylie-Rosett J, Phillips LS, Plodkowski RA & Liu S. Serum 25-hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women. American Journal of Clinical Nutrition 2011 94 209-217. (doi:10.3945/ajcn.110.010272)
12. Holick MF. Vitamin D deficiency. New England Journal of Medicine 2007 357 266-281. (doi:10.1056/NEJMra070553)
13. Mosekilde L. Vitamin D and the elderly. Clinical Endocrinology 2005 62 265-281. (doi:10.1111/j.1365-2265.2005.02226.x)
14. Holick MF. The photobiology of vitamin D and its consequences for humans. Annals of the New York Academy of Sciences 1985 453 1-13. (doi:10.1111/j.1749- 6632.1985.tb11793.x)
15. Lund B & Sorensen OH. Measurement of 25-hydroxyvitamin D in serum and its relation to sunshine, age and vitamin D intake in the Danish population. Scandinavian Journal of Clinical and Laboratory Investigation 1979 39 23-30. (doi:10.3109/00365517909104935)
16. Mosekilde L, Hermann AP, Beck NH, Charles P, Nielsen SP &Sorensen OH. The Danish Osteoporosis Prevention Study (DOPS): project design and inclusion of normal perimenopausal women. Maturitas 2000 31 207-219. (doi:10.1016/S0378- 5122(99)00006-7)
17. Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L & Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Danish Medical Bulletin 1999 46 263-268.
18. O'Connell TD & Simpson RU. Immunochemical identification of the 1,25-dihydroxyvitamin D3 receptor protein in human heart. Cell Biology International 1996 20 621-624. (doi:10.1006/cbir.1996.0081)
19. Visser M, Deeg DJ & Lips P. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. Journal of Clinical Endocrinology and Metabolism 2003 88 5766-5772. (doi:10.1210/jc.2003-030604)
20. Montero-Odasso M & Duque G. Vitamin D in the aging musculoskeletal system: an authentic strength preserving hormone. Molecular Aspects of Medicine 2005 26 203-219. (doi:10.1016/j.mam.2005.01.005)
21. Li YC, Kong J, Wei M, Chen ZF, Liu SQ & Cao LP. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. Journal of Clinical Investigation 2002110 229-238.
22. Li YC. Vitamin D regulation of the renin-angiotensin system. Journal of Cellular Biochemistry 2003 88 327-331. (doi:10.1002/jcb.10343)
23. Chen S, Law CS, Grigsby CL, Olsen K, Hong TT, Zhang Y, Yeghiazarians Y & Gardner DG. Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy. Circulation 2011 124 1838-1847. (doi:10.1161/CIRCULATIONAHA.111.032680)
24. Jablonski KL, Chonchol M, Pierce GL, Walker AE & Seals DR. 25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults. Hypertension 2011 57 63-69. (doi:10.1161/HYPERTENSIONAHA.110.160929)
25. Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P &Koerfer R. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. American Journal of Clinical Nutrition 2006 83 754-759.
26. Institute of Medicine. Dietary reference intakes for vitamin D and Calcium. Washington, DC: The National Academies Press, 2010.
27. Sun Q, Shi L, Rimm EB, Giovannucci EL, Hu FB, Manson JE &Rexrode KM. Vitamin D intake and risk of cardiovascular disease in US men and women. American Journal of Clinical Nutrition 2011 94 534-542. (doi:10.3945/ajcn.110. 008763)
28. Bolland MJ, Avenell A, Baron JA, Grey A, MacLennan GS, Gamble GD & Reid IR. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 2010 341 c3691. (doi:10.1136/bmj. c3691)
29. Mursu J, Robien K, Harnack LJ, Park K & Jacobs DR Jr. Dietary supplements and mortality rate in older women: the Iowa Women's Health Study. Archives of Internal Medicine 2011 171 1625-1633. (doi:10.1001/archinternmed. 2011.445)
30. Rejnmark L, Avenell A, Masud T, Anderson F, Meyer HE, Sanders KM, Salovaara K, Cooper C, Smith HE, Jacobs ET, Torgerson D, Jackson RD, Manson JE, Brixen K, Mosekilde L, Robbins JA, Francis RM & Abrahamsen B. Vitamin D with calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin D trials. Journal of Clinical Endocrinology and Metabolism 2012 97 2670-2681. (doi:10.1210/jc.2011-3328)
31. Elamin MB, Abu Elnour NO, Elamin KB, Fatourechi MM, Alkatib AA, Almandoz JP, Liu H, Lane MA, Mullan RJ, Hazem A, Erwin PJ, Hensrud DD, Murad MH & Montori VM. Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. Journal of Clinical Endocrinology and Metabolism 2011 96 1931-1942. (doi:10.1210/jc.2011-0398)
32. Autier P & Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Archives of Internal Medicine 2007 167 1730-1737. (doi:10.1001/archinte.167.16.1730)
33. Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti RG, Bjelakovic M & Gluud C. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database of Systematic Reviews, 2011 CD007470.
34. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D'Agostino RB, Wolf M & Vasan RS. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008 117 503-511. (doi:10.1161/ CIRCULATIONAHA.107.706127)
35. Al Mheid I, Patel R, Murrow J, Morris A, Rahman A, Fike L, Kavtaradze N, Uphoff I, Hooper C, Tangpricha V, Alexander RW, Brigham K & Quyyumi AA. Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans. Journal of the American College of Cardiology 2011 58 186-192. (doi:10.1016/j.jacc.2011.02.051)
36. Dong Y, Stallmann-Jorgensen IS, Pollock NK, Harris RA, Keeton D, Huang Y, Li K, Bassali R, Guo DH, Thomas J, Pierce GL, White J, Holick MF & Zhu H. A 16-week randomized clinical trial of 2000 international units daily vitamin D3 supplementation in black youth: 25-hydroxyvitamin D, adiposity, and arterial stiffness. Journal of Clinical Endocrinology and Metabolism 2010 95 4584-4591. (doi:10.1210/jc.2010-0606)
37. Sugden JA, Davies JI, Witham MD, Morris AD & Struthers AD. Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. Diabetic Medicine 2008 25 320-325. (doi:10.1111/j.1464-5491. 2007.02360.x)
38. Anderson JL, May HT, Horne BD, Bair TL, Hall NL, Carlquist JF, Lappé DL & Muhlestein JB. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. American Journal of Cardiology 2010 106 963-968. (doi:10.1016/j.amjcard.2010.05.027)
39. Kumar J, Muntner P, Kaskel FJ, Hailpern SM & Melamed ML. Prevalence and Associations of 25-Hydroxyvitamin D Deficiency in US Children: NHANES 2001-2004. Pediatrics 2009 124 e362-e370. (doi:10.1542/peds.2009-0051)
40. Hansen B. Vitamin D and elderly women. PhD Thesis 2003.
41. Giovannucci E, Liu Y, Hollis BW & Rimm EB. 25-Hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Archives of Internal Medicine 2008 168 1174-1180. (doi:10.1001/archinte.168.11.1174)
42. Kazlauskaite R, Powell LH, Mandapakala C, Cursio JF, Avery EF & Calvin J. Vitamin D is associated with atheroprotective high-density lipoprotein profile in postmenopausal women. Journal of Clinical Lipidology 2010 4 113-119. (doi:10.1016/j.jacl.2010.01.006)
43. Carrelli AL, Walker MD, Lowe H, McMahon DJ, Rundek T, Sacco RL & Silverberg SJ. Vitamin D deficiency is associated with subclinical carotid atherosclerosis: the Northern Manhattan study. Stroke 2011 42 2240-2245. (doi:10.1161/STROKEAHA. 110.608539)
44. Pepe J, Romagnoli E, Nofroni I, Pacitti MT, De Geronimo S, Letizia C, Tonnarini G, Scarpiello A, D'Erasmo E & Minisola S. Vitamin D status as the major factor determining the circulating levels of parathyroid hormone: a study in normal subjects. Osteoporosis International 2005 16 805-812. (doi:10.1007/s00198-004-1757-4)
45. Andersson P, Rydberg E & Willenheimer R. Primary hyperparathyroidism and heart disease - a review. European Heart Journal 2004 25 1776-1787. (doi:10.1016/j.ehj.2004.07.010)
46. Costa-Hong V, Jorgetti V, Gowdak LH, Moyses RM, Krieger EM &De Lima JJ. Parathyroidectomy reduces cardiovascular events and mortality in renal hyperparathyroidism. Surgery 2007 142 699-703. (doi:10.1016/j.surg.2007.06.015)
47. Hagstrom E, Hellman P, Larsson TE, Ingelsson E, Berglund L, Sundstrom J, Melhus H, Held C, Lind L, Michaelsson K & Arnlov J. Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation 2009 119 2765-2771. (doi:10.1161/CIRCULATIONAHA.108.808733)
48. Jorde R, Svartberg J & Sundsfjord J. Serum parathyroid hormone as a predictor of increase in systolic blood pressure in men. Journal of Hypertension 2005 23 1639-1644. (doi:10.1097/01.hjh.0000179764.40701.36)
49. Kamycheva E, Sundsfjord J & Jorde R. Serum parathyroid hormone levels predict coronary heart disease: the Tromso Study [Article]. European Journal of Cardiovascular Prevention and Rehabilitation 2004 11 69-74. (doi:10.1097/01.hjr.0000114706.27531.01)
50. Cozzolino M, Ketteler M & Zehnder D. The vitamin D system: a crosstalk between the heart and kidney. European Journal of Heart Failure 2010 12 1031-1041. (doi:10.1093/eurjhf/hfq112)
51. Nemerovski CW, Dorsch MP, Simpson RU, Bone HG, Aaronson KD &Bleske BE. Vitamin D and cardiovascular disease. Pharmacotherapy 2009 29 691-708. (doi:10.1592/phco.29.6.691)
52. Pilz S, Tomaschitz A, Drechsler C, Dekker JM & Marz W. Vitamin D deficiency and myocardial diseases. Molecular Nutrition & Food Research 2010 54 1103-1113. (doi:10.1002/mnfr.200900474)
53. Rosen CJ, Adams JS, Bikle DD, Black DM, Demay MB, Manson JE, Murad MH & Kovacs CS. The nonskeletal effects of vitamin D: an endocrine society scientific statement. Endocrine Reviews 2012 33 456-492. (doi:10.1210/er.2012- 1000)
54. Durup D, Jorgensen HL, Christensen J, Schwarz P, Heegaard AM &Lind B. A reverse J-shaped association of all-cause mortality with serum 25-hydroxyvitamin D in general practice, the CopD Study. Journal of Clinical Endocrinology and Metabolism 2012 97 2644-2652. (doi:10.1210/jc.2012-1176)
55. Melamed ML, Michos ED, Post W & Astor B. 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Archives of Internal Medicine 2008 168 1629-1637. (doi:10.1001/archinte.168.15.1629)